These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis. Brandi L. Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159 [Abstract] [Full Text] [Related]
3. Treatment of hypocalcemia caused by hypoparathyroidism or pseudohypoparathyroidism with domestic-made calcitriol: a prospective and self-controlled clinical trial. Wang O, Xing XP, Meng XW, Xia WB, Li M, Jiang Y, Hu YY, Liu HC. Chin Med J (Engl); 2009 Feb 05; 122(3):279-83. PubMed ID: 19236804 [Abstract] [Full Text] [Related]
4. Management of Hypoparathyroidism: Present and Future. Bilezikian JP, Brandi ML, Cusano NE, Mannstadt M, Rejnmark L, Rizzoli R, Rubin MR, Winer KK, Liberman UA, Potts JT. J Clin Endocrinol Metab; 2016 Jun 05; 101(6):2313-24. PubMed ID: 26938200 [Abstract] [Full Text] [Related]
5. [Hypoparathyroidism: the present state of art]. Krysiak R, Handzlik-Orlik G, Kedzia A, Machnik G, Okopień B. Wiad Lek; 2013 Jun 05; 66(1):18-29. PubMed ID: 23905424 [Abstract] [Full Text] [Related]
6. Hypocalcemic disorders. Bove-Fenderson E, Mannstadt M. Best Pract Res Clin Endocrinol Metab; 2018 Oct 05; 32(5):639-656. PubMed ID: 30449546 [Abstract] [Full Text] [Related]
7. Primary hypoparathyroidism in dogs: a retrospective study of 17 cases. Russell NJ, Bond KA, Robertson ID, Parry BW, Irwin PJ. Aust Vet J; 2006 Aug 05; 84(8):285-90. PubMed ID: 16911229 [Abstract] [Full Text] [Related]
8. Postoperative hypoparathyroidism: medical and surgical therapeutic options. Walker Harris V, Jan De Beur S. Thyroid; 2009 Sep 05; 19(9):967-73. PubMed ID: 19731978 [Abstract] [Full Text] [Related]
9. Intraoperative parathyroid hormone levels in thyroid surgery are predictive of postoperative hypoparathyroidism and need for vitamin D supplementation. Quiros RM, Pesce CE, Wilhelm SM, Djuricin G, Prinz RA. Am J Surg; 2005 Mar 05; 189(3):306-9. PubMed ID: 15792756 [Abstract] [Full Text] [Related]
10. Pharmacokinetics and pharmacodynamics of subcutaneous recombinant parathyroid hormone (1-84) in patients with hypoparathyroidism: an open-label, single-dose, phase I study. Clarke BL, Kay Berg J, Fox J, Cyran JA, Lagast H. Clin Ther; 2014 May 05; 36(5):722-36. PubMed ID: 24802860 [Abstract] [Full Text] [Related]
11. Hypoparathyroidism and pseudohypoparathyroidism. Maeda SS, Fortes EM, Oliveira UM, Borba VC, Lazaretti-Castro M. Arq Bras Endocrinol Metabol; 2006 Aug 05; 50(4):664-73. PubMed ID: 17117292 [Abstract] [Full Text] [Related]
12. Predicting the need for calcium and calcitriol supplementation after total thyroidectomy: results of a prospective, randomized study. Cayo AK, Yen TW, Misustin SM, Wall K, Wilson SD, Evans DB, Wang TS. Surgery; 2012 Dec 05; 152(6):1059-67. PubMed ID: 23068088 [Abstract] [Full Text] [Related]
13. The role of rapid PACU parathyroid hormone in reducing post-thyroidectomy hypocalcemia. Sabour S, Manders E, Steward DL. Otolaryngol Head Neck Surg; 2009 Dec 05; 141(6):727-9. PubMed ID: 19932845 [Abstract] [Full Text] [Related]
19. Pathogenesis and management of hypoparathyroidism and other hypocalcemic disorders. Schneider AB, Sherwood LM. Metabolism; 1975 Jul 05; 24(7):871-98. PubMed ID: 166271 [Abstract] [Full Text] [Related]
20. Drug safety evaluation of parathyroid hormone for hypocalcemia in patients with hypoparathyroidism. Marcucci G, Della Pepa G, Brandi ML. Expert Opin Drug Saf; 2017 May 05; 16(5):617-625. PubMed ID: 28332412 [Abstract] [Full Text] [Related] Page: [Next] [New Search]